Government claims measures to cut MRSA and C difficile rates will help reduce other infections

BMJ 2009; 338 doi: 10.1136/bmj.b2580 (Published 26 June 2009)
Cite this as: BMJ 2009;338:b2580

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Adrian O’Dowd
  1. 1London

    NHS leaders have told MPs that the success in reducing well known infections that are acquired in hospital will lead to a reduction in other infections. The parliamentary public accounts committee quizzed witnesses this week as part of its inquiry into the National Audit Office report on reducing healthcare associated infections in hospitals, which was published earlier this month.

    The MPs asked what next for these infections after concerns in the report that other infections would become a greater problem than meticillin resistant Staphylococcus aureus (MRSA) and Clostridium difficile.

    The committee chairman, Edward Leigh, Conservative MP for Gainsborough, congratulated the NHS chief executive, David Nicholson, on the …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL